BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35461703)

  • 1. De novo POLR2A p.(Ile457Thr) variant associated with early-onset encephalopathy and cerebellar atrophy: expanding the phenotypic spectrum.
    Giacomini T; Scala M; Nobile G; Severino M; Tortora D; Nobili L; Accogli A; Torella A; Capra V; Mancardi MM; Nigro V;
    Brain Dev; 2022 Aug; 44(7):480-485. PubMed ID: 35461703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex Autism Spectrum Disorder with Epilepsy, Strabismus and Self-Injurious Behaviors in a Patient with a De Novo Heterozygous
    Evans DR; Qiao Y; Trost B; Calli K; Martell S; Jones SJM; Scherer SW; Lewis MES
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MED13 mutation: A novel cause of developmental and epileptic encephalopathy with infantile spasms.
    Trivisano M; De Dominicis A; Micalizzi A; Ferretti A; Dentici ML; Terracciano A; Calabrese C; Vigevano F; Novelli G; Novelli A; Specchio N
    Seizure; 2022 Oct; 101():211-217. PubMed ID: 36087421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De Novo Heterozygous POLR2A Variants Cause a Neurodevelopmental Syndrome with Profound Infantile-Onset Hypotonia.
    Haijes HA; Koster MJE; Rehmann H; Li D; Hakonarson H; Cappuccio G; Hancarova M; Lehalle D; Reardon W; Schaefer GB; Lehman A; van de Laar IMBH; Tesselaar CD; Turner C; Goldenberg A; Patrier S; Thevenon J; Pinelli M; Brunetti-Pierri N; Prchalová D; Havlovicová M; Vlckova M; Sedláček Z; Lopez E; Ragoussis V; Pagnamenta AT; Kini U; Vos HR; van Es RM; van Schaik RFMA; van Essen TAJ; Kibaek M; Taylor JC; Sullivan J; Shashi V; Petrovski S; Fagerberg C; Martin DM; van Gassen KLI; Pfundt R; Falk MJ; McCormick EM; Timmers HTM; van Hasselt PM
    Am J Hum Genet; 2019 Aug; 105(2):283-301. PubMed ID: 31353023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biallelic CACNA1A mutations cause early onset epileptic encephalopathy with progressive cerebral, cerebellar, and optic nerve atrophy.
    Reinson K; Õiglane-Shlik E; Talvik I; Vaher U; Õunapuu A; Ennok M; Teek R; Pajusalu S; Murumets Ü; Tomberg T; Puusepp S; Piirsoo A; Reimand T; Õunap K
    Am J Med Genet A; 2016 Aug; 170(8):2173-6. PubMed ID: 27250579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
    Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K
    Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delineating SPTAN1 associated phenotypes: from isolated epilepsy to encephalopathy with progressive brain atrophy.
    Syrbe S; Harms FL; Parrini E; Montomoli M; Mütze U; Helbig KL; Polster T; Albrecht B; Bernbeck U; van Binsbergen E; Biskup S; Burglen L; Denecke J; Heron B; Heyne HO; Hoffmann GF; Hornemann F; Matsushige T; Matsuura R; Kato M; Korenke GC; Kuechler A; Lämmer C; Merkenschlager A; Mignot C; Ruf S; Nakashima M; Saitsu H; Stamberger H; Pisano T; Tohyama J; Weckhuysen S; Werckx W; Wickert J; Mari F; Verbeek NE; Møller RS; Koeleman B; Matsumoto N; Dobyns WB; Battaglia D; Lemke JR; Kutsche K; Guerrini R
    Brain; 2017 Sep; 140(9):2322-2336. PubMed ID: 29050398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posterior fossa ependymoma in neurodevelopmental syndrome caused by a de novo germline pathogenic POLR2A variant.
    Paparella R; Caroleo AM; Agolini E; Chillemi G; Miele E; Pedace L; Rinelli M; Pizzi S; Boccuto L; Colafati GS; Lodi M; Cacchione A; Carai A; Digilio MC; Tomà P; Tartaglia M; Mastronuzzi A
    Am J Med Genet A; 2022 Sep; 188(9):2796-2802. PubMed ID: 35689525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A patient with pontocerebellar hypoplasia type 6: Novel RARS2 mutations, comparison to previously published patients and clinical distinction from PEHO syndrome.
    Nevanlinna V; Konovalova S; Ceulemans B; Muona M; Laari A; Hilander T; Gorski K; Valanne L; Anttonen AK; Tyynismaa H; Courage C; Lehesjoki AE
    Eur J Med Genet; 2020 Mar; 63(3):103766. PubMed ID: 31536827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trio exome sequencing identified a novel de novo WASF1 missense variant leading to recurrent site substitution in a Chinese patient with developmental delay, microcephaly, and early-onset seizures: A mutational hotspot p.Trp161 and literature review.
    Zhao A; Zhou R; Gu Q; Liu M; Zhang B; Huang J; Yang B; Yao R; Wang J; Lv H; Wang J; Shen Y; Wang H; Chen X
    Clin Chim Acta; 2021 Dec; 523():10-18. PubMed ID: 34478686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early infantile epileptic encephalopathy caused by PACS2 gene variation: three cases report and literature review].
    Wu MJ; Hu CH; Ma JH; Hu JS; Liu ZS; Sun D
    Zhonghua Er Ke Za Zhi; 2021 Jul; 59(7):594-599. PubMed ID: 34405643
    [No Abstract]   [Full Text] [Related]  

  • 12. The molecular and phenotypic spectrum of IQSEC2-related epilepsy.
    Zerem A; Haginoya K; Lev D; Blumkin L; Kivity S; Linder I; Shoubridge C; Palmer EE; Field M; Boyle J; Chitayat D; Gaillard WD; Kossoff EH; Willems M; Geneviève D; Tran-Mau-Them F; Epstein O; Heyman E; Dugan S; Masurel-Paulet A; Piton A; Kleefstra T; Pfundt R; Sato R; Tzschach A; Matsumoto N; Saitsu H; Leshinsky-Silver E; Lerman-Sagie T
    Epilepsia; 2016 Nov; 57(11):1858-1869. PubMed ID: 27665735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Recurrent De Novo PACS2 Heterozygous Missense Variant Causes Neonatal-Onset Developmental Epileptic Encephalopathy, Facial Dysmorphism, and Cerebellar Dysgenesis.
    Olson HE; Jean-Marçais N; Yang E; Heron D; Tatton-Brown K; van der Zwaag PA; Bijlsma EK; Krock BL; Backer E; Kamsteeg EJ; Sinnema M; Reijnders MRF; Bearden D; Begtrup A; Telegrafi A; Lunsing RJ; Burglen L; Lesca G; Cho MT; Smith LA; Sheidley BR; Moufawad El Achkar C; Pearl PL; Poduri A; Skraban CM; Tarpinian J; Nesbitt AI; Fransen van de Putte DE; Ruivenkamp CAL; Rump P; Chatron N; Sabatier I; De Bellescize J; Guibaud L; Sweetser DA; Waxler JL; Wierenga KJ; ; Donadieu J; Narayanan V; Ramsey KM; ; Nava C; Rivière JB; Vitobello A; Tran Mau-Them F; Philippe C; Bruel AL; Duffourd Y; Thomas L; Lelieveld SH; Schuurs-Hoeijmakers J; Brunner HG; Keren B; Thevenon J; Faivre L; Thomas G; Thauvin-Robinet C
    Am J Hum Genet; 2018 May; 102(5):995-1007. PubMed ID: 29656858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infantile-Onset Syndromic Cerebellar Ataxia and CACNA1G Mutations.
    Barresi S; Dentici ML; Manzoni F; Bellacchio E; Agolini E; Pizzi S; Ciolfi A; Tarnopolsky M; Brady L; Garone G; Novelli A; Mei D; Guerrini R; Capuano A; Pantaleoni C; Tartaglia M
    Pediatr Neurol; 2020 Mar; 104():40-45. PubMed ID: 31836334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biallelic CACNA2D2 variants in epileptic encephalopathy and cerebellar atrophy.
    Punetha J; Karaca E; Gezdirici A; Lamont RE; Pehlivan D; Marafi D; Appendino JP; Hunter JV; Akdemir ZC; Fatih JM; Jhangiani SN; Gibbs RA; Innes AM; Posey JE; Lupski JR
    Ann Clin Transl Neurol; 2019 Aug; 6(8):1395-1406. PubMed ID: 31402629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo mutations of TUBB2A cause infantile-onset epilepsy and developmental delay.
    Cai S; Li J; Wu Y; Jiang Y
    J Hum Genet; 2020 Jul; 65(7):601-608. PubMed ID: 32203252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary neurotransmitter deficiencies in epilepsy caused by voltage-gated sodium channelopathies: A potential treatment target?
    Horvath GA; Demos M; Shyr C; Matthews A; Zhang L; Race S; Stockler-Ipsiroglu S; Van Allen MI; Mancarci O; Toker L; Pavlidis P; Ross CJ; Wasserman WW; Trump N; Heales S; Pope S; Cross JH; van Karnebeek CD
    Mol Genet Metab; 2016 Jan; 117(1):42-8. PubMed ID: 26647175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATP1A2- and ATP1A3-associated early profound epileptic encephalopathy and polymicrogyria.
    Vetro A; Nielsen HN; Holm R; Hevner RF; Parrini E; Powis Z; Møller RS; Bellan C; Simonati A; Lesca G; Helbig KL; Palmer EE; Mei D; Ballardini E; Van Haeringen A; Syrbe S; Leuzzi V; Cioni G; Curry CJ; Costain G; Santucci M; Chong K; Mancini GMS; Clayton-Smith J; Bigoni S; Scheffer IE; Dobyns WB; Vilsen B; Guerrini R;
    Brain; 2021 Jun; 144(5):1435-1450. PubMed ID: 33880529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel imaging and clinical phenotypes of CONDSIAS disorder caused by a homozygous frameshift variant of ADPRHL2: a case report.
    Aryan H; Razmara E; Farhud D; Zarif-Yeganeh M; Zokaei S; Hassani SA; Ashrafi MR; Garshasbi M; Tavasoli AR
    BMC Neurol; 2020 Aug; 20(1):291. PubMed ID: 32746785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe early-onset epileptic encephalopathy due to mutations in the KCNA2 gene: Expansion of the genotypic and phenotypic spectrum.
    Hundallah K; Alenizi A; AlHashem A; Tabarki B
    Eur J Paediatr Neurol; 2016 Jul; 20(4):657-60. PubMed ID: 27117551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.